[Locally acting corticosteroids in inflammatory bowel disease. Are they effective? Are they really less toxic?]

Gastroenterol Hepatol. 2008 Sep:31 Suppl 3:16-21.
[Article in Spanish]
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Administration, Oral
  • Adrenal Cortex Hormones / administration & dosage*
  • Adrenal Cortex Hormones / adverse effects
  • Adrenal Cortex Hormones / pharmacokinetics
  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Androstadienes / administration & dosage
  • Androstadienes / adverse effects
  • Androstadienes / pharmacokinetics
  • Androstadienes / therapeutic use
  • Anti-Inflammatory Agents / administration & dosage*
  • Anti-Inflammatory Agents / adverse effects
  • Anti-Inflammatory Agents / pharmacokinetics
  • Anti-Inflammatory Agents / therapeutic use
  • Beclomethasone / administration & dosage
  • Beclomethasone / adverse effects
  • Beclomethasone / pharmacokinetics
  • Beclomethasone / therapeutic use
  • Budesonide / administration & dosage
  • Budesonide / adverse effects
  • Budesonide / pharmacokinetics
  • Budesonide / therapeutic use
  • Controlled Clinical Trials as Topic / statistics & numerical data
  • Cushing Syndrome / chemically induced
  • Delayed-Action Preparations
  • Double-Blind Method
  • Fluticasone
  • Humans
  • Inflammatory Bowel Diseases / drug therapy*
  • Intestinal Absorption
  • Meta-Analysis as Topic
  • Randomized Controlled Trials as Topic / statistics & numerical data
  • Remission Induction

Substances

  • Adrenal Cortex Hormones
  • Androstadienes
  • Anti-Inflammatory Agents
  • Delayed-Action Preparations
  • Budesonide
  • Fluticasone
  • Beclomethasone